- Home
- DHI vs ALC Comparison
DHI vs ALC Comparison
Compare DHI & ALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DHI
- ALC
- Stock Information
- Founded
- DHI 1978
- ALC 1945
- Country
- DHI United States
- ALC Switzerland
- Employees
- DHI N/A
- ALC N/A
- Industry
- DHI Homebuilding
- ALC Ophthalmic Goods
- Sector
- DHI Consumer Discretionary
- ALC Health Care
- Exchange
- DHI Nasdaq
- ALC Nasdaq
- Market Cap
- DHI 44.0B
- ALC 46.8B
- IPO Year
- DHI 1992
- ALC N/A
- Fundamental
- Price
- DHI $118.02
- ALC $85.92
- Analyst Decision
- DHI Buy
- ALC Buy
- Analyst Count
- DHI 14
- ALC 10
- Target Price
- DHI $161.23
- ALC $107.00
- AVG Volume (30 Days)
- DHI 3.1M
- ALC 1.9M
- Earning Date
- DHI 07-22-2025
- ALC 05-13-2025
- Dividend Yield
- DHI 1.35%
- ALC 0.39%
- EPS Growth
- DHI N/A
- ALC 6.66
- EPS
- DHI 13.25
- ALC 2.25
- Revenue
- DHI $35,315,300,000.00
- ALC $9,925,000,000.00
- Revenue This Year
- DHI N/A
- ALC $6.22
- Revenue Next Year
- DHI $3.47
- ALC $7.16
- P/E Ratio
- DHI $8.91
- ALC $38.03
- Revenue Growth
- DHI N/A
- ALC 3.80
- 52 Week Low
- DHI $110.44
- ALC $80.48
- 52 Week High
- DHI $199.85
- ALC $101.10
- Technical
- Relative Strength Index (RSI)
- DHI 41.59
- ALC 36.60
- Support Level
- DHI $117.07
- ALC $84.94
- Resistance Level
- DHI $121.48
- ALC $87.64
- Average True Range (ATR)
- DHI 2.81
- ALC 1.64
- MACD
- DHI -0.55
- ALC -0.58
- Stochastic Oscillator
- DHI 8.98
- ALC 9.42
About DHI D.R. Horton Inc.
D.R. Horton is a leading homebuilder in the United States with operations in 126 markets across 36 states. D.R. Horton mainly builds single-family detached homes (87% of home sales revenue) and offers products to entry-level, move-up, luxury buyers, and active adults. The company offers homebuyers mortgage financing and title agency services through its financial services segment. D.R. Horton's headquarters are in Arlington, Texas, and it manages six regional segments across the United States.
About ALC Alcon Inc.
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.